Noxxon raises EUR 33 million

Noxxon Pharma AG (Berlin, Germany) raised EUR 33 million ($41.2 million) in a series D round led by new investor NGN Capital. Existing investors TVM Capital; Sofinnova Partners; Edmond de Rothschild Investment Partners; Seventure Partners; VC Fonds Technologie Berlin; Dow Venture Capital; FCP OP Medical BioHealth-Trends; IBG Beteiligungsgesellschaft Sachsen-Anhalt; and the Dieckell Group also participated. ...